Antiemesis

Clinical practice guidelines in Oncology™

David S. Ettinger, Philip Jay Bierman, Bob Bradbury, Carli C. Comish, Georgiana Ellis, Robert J. Ignoffo, Steve Kirkegaard, Dwight D. Kloth, Mark G. Kris, Dean Lim, Michael Anne Markiewicz, Robert McNulty, Lidia Nabati, Barbara Todaro, Susan Urba, Sally Yowell

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Chemotherapy-induced nausea and vomiting (emesis) can significantly affect a patient's quality of life, leading to poor adherence with further chemotherapy treatment. In addition, nausea and vomiting can result in other serious complications and deterioration of the patient's status. These guidelines explore the prevention, treatment, and management of various types of emesis experienced by cancer patients, such as breakthrough, radiation-induced, and anticipatory.

Original languageEnglish (US)
Pages (from-to)12-33
Number of pages22
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume5
Issue number1
StatePublished - Jan 1 2007

Fingerprint

Practice Guidelines
Vomiting
Nausea
Drug Therapy
Quality of Life
Guidelines
Radiation
Therapeutics
Neoplasms

Keywords

  • 5-HT3 receptor antagonists
  • Anticipatory emesis
  • Antiemesis
  • Aprepitant
  • Chemotherapy-induced emesis
  • NCCN Clinical Practice Guidelines
  • NK-1-receptor antagonists
  • Nausea and vomiting
  • Palonosetron
  • Radiation-induced emesis

ASJC Scopus subject areas

  • Oncology

Cite this

Ettinger, D. S., Bierman, P. J., Bradbury, B., Comish, C. C., Ellis, G., Ignoffo, R. J., ... Yowell, S. (2007). Antiemesis: Clinical practice guidelines in Oncology™. JNCCN Journal of the National Comprehensive Cancer Network, 5(1), 12-33.

Antiemesis : Clinical practice guidelines in Oncology™. / Ettinger, David S.; Bierman, Philip Jay; Bradbury, Bob; Comish, Carli C.; Ellis, Georgiana; Ignoffo, Robert J.; Kirkegaard, Steve; Kloth, Dwight D.; Kris, Mark G.; Lim, Dean; Markiewicz, Michael Anne; McNulty, Robert; Nabati, Lidia; Todaro, Barbara; Urba, Susan; Yowell, Sally.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 5, No. 1, 01.01.2007, p. 12-33.

Research output: Contribution to journalArticle

Ettinger, DS, Bierman, PJ, Bradbury, B, Comish, CC, Ellis, G, Ignoffo, RJ, Kirkegaard, S, Kloth, DD, Kris, MG, Lim, D, Markiewicz, MA, McNulty, R, Nabati, L, Todaro, B, Urba, S & Yowell, S 2007, 'Antiemesis: Clinical practice guidelines in Oncology™', JNCCN Journal of the National Comprehensive Cancer Network, vol. 5, no. 1, pp. 12-33.
Ettinger DS, Bierman PJ, Bradbury B, Comish CC, Ellis G, Ignoffo RJ et al. Antiemesis: Clinical practice guidelines in Oncology™. JNCCN Journal of the National Comprehensive Cancer Network. 2007 Jan 1;5(1):12-33.
Ettinger, David S. ; Bierman, Philip Jay ; Bradbury, Bob ; Comish, Carli C. ; Ellis, Georgiana ; Ignoffo, Robert J. ; Kirkegaard, Steve ; Kloth, Dwight D. ; Kris, Mark G. ; Lim, Dean ; Markiewicz, Michael Anne ; McNulty, Robert ; Nabati, Lidia ; Todaro, Barbara ; Urba, Susan ; Yowell, Sally. / Antiemesis : Clinical practice guidelines in Oncology™. In: JNCCN Journal of the National Comprehensive Cancer Network. 2007 ; Vol. 5, No. 1. pp. 12-33.
@article{cc2016c735314e719fc3562c7eb724a5,
title = "Antiemesis: Clinical practice guidelines in Oncology™",
abstract = "Chemotherapy-induced nausea and vomiting (emesis) can significantly affect a patient's quality of life, leading to poor adherence with further chemotherapy treatment. In addition, nausea and vomiting can result in other serious complications and deterioration of the patient's status. These guidelines explore the prevention, treatment, and management of various types of emesis experienced by cancer patients, such as breakthrough, radiation-induced, and anticipatory.",
keywords = "5-HT3 receptor antagonists, Anticipatory emesis, Antiemesis, Aprepitant, Chemotherapy-induced emesis, NCCN Clinical Practice Guidelines, NK-1-receptor antagonists, Nausea and vomiting, Palonosetron, Radiation-induced emesis",
author = "Ettinger, {David S.} and Bierman, {Philip Jay} and Bob Bradbury and Comish, {Carli C.} and Georgiana Ellis and Ignoffo, {Robert J.} and Steve Kirkegaard and Kloth, {Dwight D.} and Kris, {Mark G.} and Dean Lim and Markiewicz, {Michael Anne} and Robert McNulty and Lidia Nabati and Barbara Todaro and Susan Urba and Sally Yowell",
year = "2007",
month = "1",
day = "1",
language = "English (US)",
volume = "5",
pages = "12--33",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "1",

}

TY - JOUR

T1 - Antiemesis

T2 - Clinical practice guidelines in Oncology™

AU - Ettinger, David S.

AU - Bierman, Philip Jay

AU - Bradbury, Bob

AU - Comish, Carli C.

AU - Ellis, Georgiana

AU - Ignoffo, Robert J.

AU - Kirkegaard, Steve

AU - Kloth, Dwight D.

AU - Kris, Mark G.

AU - Lim, Dean

AU - Markiewicz, Michael Anne

AU - McNulty, Robert

AU - Nabati, Lidia

AU - Todaro, Barbara

AU - Urba, Susan

AU - Yowell, Sally

PY - 2007/1/1

Y1 - 2007/1/1

N2 - Chemotherapy-induced nausea and vomiting (emesis) can significantly affect a patient's quality of life, leading to poor adherence with further chemotherapy treatment. In addition, nausea and vomiting can result in other serious complications and deterioration of the patient's status. These guidelines explore the prevention, treatment, and management of various types of emesis experienced by cancer patients, such as breakthrough, radiation-induced, and anticipatory.

AB - Chemotherapy-induced nausea and vomiting (emesis) can significantly affect a patient's quality of life, leading to poor adherence with further chemotherapy treatment. In addition, nausea and vomiting can result in other serious complications and deterioration of the patient's status. These guidelines explore the prevention, treatment, and management of various types of emesis experienced by cancer patients, such as breakthrough, radiation-induced, and anticipatory.

KW - 5-HT3 receptor antagonists

KW - Anticipatory emesis

KW - Antiemesis

KW - Aprepitant

KW - Chemotherapy-induced emesis

KW - NCCN Clinical Practice Guidelines

KW - NK-1-receptor antagonists

KW - Nausea and vomiting

KW - Palonosetron

KW - Radiation-induced emesis

UR - http://www.scopus.com/inward/record.url?scp=33846786930&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846786930&partnerID=8YFLogxK

M3 - Article

VL - 5

SP - 12

EP - 33

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

SN - 1540-1405

IS - 1

ER -